Status: Recruiting
AOH1996 for the Treatment of Refractory Solid Tumors
This phase I trial studies the side effects and best dose of AOH1996 in treating patients with solid tumors that do not respond to treatment (refractory). AOH1996 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Participants needed: 92
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: City of Hope Medical CenterUpdated: Sep 18, 2025Locations: 2
Eligibility criteria
1. Documented informed consent by the participant [+10]
2. Other investigational products or chemotherapy. Exception: EGFR TKI in the NS... [+9]